ArthroFLEX® Decellularized Dermal Allograft

ArthroFlex® dermal allograft is an acellular dermal extracellular matrix intended for supplemental support and covering for soft-tissue repair. Matracell^® technology, a patented and validated process, renders the ArthroFlex allograft dermis acellular without compromising biomechanical or biochemical properties. This process allows the matrix to retain its growth factors, native collagen scaffold, and elastin, which are required for healing.¹ ArthroFlex dermal allograft improves the strength of the repair and protects it to allow healing.^2,3 Matracell technology removes donor DNA from the dermal matrix, ensuring a biocompatible scaffold to facilitate repair.

_References

_{1. Moore MA, Samsell B, Wallis G, et al. Decellularization of human dermis using non-denaturing anionic detergent and endonuclease: a review. Cell Tissue Bank. 2015;16(2):249-259. doi:10.1007/s10561-014-9467-4}

_{2. Gilot GJ, Alvarez-Pinzon AM, Barcksdale L, Westerdahl D, Krill M, Peck E. Outcome of large to massive rotator cuff tears repaired with and without extracellular matrix augmentation: a prospective comparative study. Arthroscopy. 2015;31(8):1459-1465. doi:10.1016/j.arthro.2015.02.032}

_{3. Ely EE, Figueroa NM, Gilot GJ. Biomechanical analysis of rotator cuff repairs with extracellular matrix graft augmentation. Orthopedics. 2014;37(9):608-614. doi:10.3928/01477447-20140825-05}

_{ArthroFlex and Matracell are registered trademarks of LifeNet Health.}